Die Nicht-CPAP-Therapie des obstruktiven Schlafapnoe-Syndroms: ein Überblick

S. Keymel; M. Kelm; W. J. Randerath

doi:10.1055/s-0032-1325903

Pneumologie, Inhaltsverzeichnis

Pneumologie 2013; 67(01): 50-57
DOI: 10.1055/s-0032-1325903

Übersicht

Die Nicht-CPAP-Therapie des obstruktiven Schlafapnoe-Syndroms: ein Überblick

Non-CPAP Therapies in Obstructive Sleep Apnoea: An Overview

S. Keymel

¹Heinrich-Heine Universität Düsseldorf, Medizinische Fakultät, Klinik für Kardiologie, Pneumologie und Angiologie, Universitätsklinikum Düsseldorf

,

M. Kelm

¹Heinrich-Heine Universität Düsseldorf, Medizinische Fakultät, Klinik für Kardiologie, Pneumologie und Angiologie, Universitätsklinikum Düsseldorf

,

W. J. Randerath

²Institut für Pneumologie an der Universität Witten/Herdecke, Klinik für Pneumologie und Allergologie, Zentrum für Schlaf- und Beatmungsmedizin, Krankenhaus Bethanien, Solingen

› Institutsangaben

Abstract

Zusammenfassung

Die optimale Therapie des obstruktiven Schlafapnoe-Syndroms erfordert ein individuell und interdisziplinär ausgerichtetes Konzept. Als Standardtherapie wird die nächtliche Überdruckatmung (CPAP = continuous positive airway pressure) angesehen. Darüber hinaus existiert ein umfangreiches Repertoire an Nicht-CPAP-Therapien, die insbesondere bei Versagen oder Ablehnung der nächtlichen Überdruckatmung zum Einsatz kommen. Limitierend in der Bewertung der Nicht-CPAP-Therapie ist jedoch die vorwiegend unzureichende Evidenz der Nicht-CPAP-Therapien. Als konservative Maßnahme kann die Unterkieferprotrusionsschiene bei leichtem bis moderatem OSAS zum Einsatz kommen. Die bisher präklinisch eingesetzte Neurostimulation der Muskulatur der oberen Atemwege stellt einen attraktiven Ansatz zur Behandlung des OSAS dar, der sich jedoch in klinischen Studien noch beweisen muss. Isolierte chirurgische Maßnahmen der Nase, des Oropharynx oder des Hypopharynx können aufgrund der geringen Erfolgsrate im Allgemeinen nicht empfohlen werden. Ausnahmen stellen die Tonsillektomie bei Vergrößerung der Tonsillen und die aufwendige maxillomandibuläre Umstellungsosteotomie dar. Ein potenzieller Ansatz der chirurgischen Therapie des OSAS für die Zukunft stellt die Multi-Level-Chirurgie dar.

Abstract

Optimal treatment of the obstructive sleep apnoea syndrome (OSAS) requires an individually designed and interdisciplinary approach. Continu ous positive airway pressure (CPAP) is accepted as the first line therapy for patients with OSAS. However, non-CPAP therapies may be indicated as supportive therapeutical approach in CPAP failure or as an alternative approach in CPAP intolerance. Overall, the level of evidence for the majority of non-CPAP therapies is low. Mandibular advancement devices as a medical non-CPAP treatment have proven to reduce respiratory disturbances to a level which may be sufficient in mild to moderate sleep apnoea. Apnoea triggered neurostimulation of upper airway muscles is an innovative approach that has shown promising results in preclinical studies. Surgical treatment has previously been performed as single level surgery of the nasal, the oropharyngeal or hypopharyngeal level. However, only tonsillectomy in the presence of tonsillar hypertrophy and maxillomandibular advancement are recommended in carefully selected cases. Due to low success rates for single level surgery, multilevel surgery has been proposed as the surgical approach for the future.

Volltext

Referenzen

Literatur
1 Young T, Palta M, Dempsey J et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-1235
2 Basner RC. Continuous positive airway pressure for obstructive sleep apnea. N Engl J Med 2007; 356: 1751-1758
3 Gay P, Weaver T, Loube D et al. Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults. Sleep 2006; 29: 381-401
4 Deutsche Gesellschaft für Schlafforschung und Schlafmedizin (DGSM). S3-Leitlinie Nicht erholsamer Schlaf/Schlafstörungen. Somnologie 2009; 13 (Suppl. 01) 4-160
5 Eckert DJ, Malhotra A, Jordan AS. Mechanisms of apnea. Prog Cardiovasc Dis 2009; 51: 313-323
6 Malhotra A, Pillar G, Fogel R et al. Upper-airway collapsibility: measurements and sleep effects. Chest 2001; 120: 156-161
7 Schellenberg JB, Maislin G, Schwab RJ. Physical findings and the risk for obstructive sleep apnea. The importance of oropharyngeal structures. Am J Respir Crit Care Med 2000; 162: 740-748
8 Schwab RJ, Pasirstein M, Pierson R et al. Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging. Am J Respir Crit Care Med 2003; 168: 522-530
9 Yu X, Fujimoto K, Urushibata K et al. Cephalometric analysis in obese and nonobese patients with obstructive sleep apnea syndrome. Chest 2003; 124: 212-218
10 Remmers JE, deGroot WJ, Sauerland EK et al. Pathogenesis of upper airway occlusion during sleep. J Appl Physiol 1978; 44: 931-938
11 Mezzanotte WS, Tangel DJ, White DP. Waking genioglossal electromyogram in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism). J Clin Invest 1992; 89: 1571-1579
12 Saboisky JP, Stashuk DW, Hamilton-Wright A et al. Neurogenic changes in the upper airway of patients with obstructive sleep apnea. Am J Respir Crit Care Med 2012; 185: 322-329
13 Young T, Blustein J, Finn L et al. Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults. Sleep 1997; 20: 608-613
14 Shahar E, Whitney CW, Redline S et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001; 163: 19-25
15 Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 2006; 28: 596-602
16 Peppard PE, Young T, Palta M et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-1384
17 Mancia G, De Backer G, Dominiczak A et al. 2007 Guidelines of the management of arterial hypertension. The task force of the management of arterial hypertension of the european society of hypertension (ESH) and the european society of cardiology (ESC). Eur Heart J 2007; 28: 1462-1536
18 Yumino D, Tsurumi Y, Takagi A et al. Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol 2007; 99: 26-30
19 Steiner S, Schueller PO, Hennersdorf MG et al. Impact of obstructive sleep apnea on the occurrence of restenosis after elective percutaneous coronary intervention in ischemic heart disease. Respir Res 2008; 9: 50
20 Peker Y, Hedner J, Kraiczi H et al. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000; 162: 81-86
21 Gami AS, Pressman G, Caples SM et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004; 110: 364-367
22 Ng CY, Liu T, Shehata M et al. Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am J Cardiol 2011; 108: 47-51
23 Mehra R, Stone KL, Varosy PD et al. Nocturnal Arrhythmias across a spectrum of obstructive and central sleep-disordered breathing in older men: outcomes of sleep disorders in older men (MrOS sleep) study. Arch Intern Med 2009; 169: 1147-1155
24 Koehler U, Fus E, Grimm W et al. Heart block in patients with obstructive sleep apnoea: pathogenetic factors and effects of treatment. Eur Respir J 1998; 11: 434-439
25 Stevenson IH, Teichtahl H, Cunnington D et al. Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function. Eur Heart J 2008; 29: 1662-1669
26 Kanagala R, Murali NS, Friedman PA et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003; 107: 2589-2594
27 Kushida CA, Littner MR, Hirshkowitz M et al. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep 2006; 29: 375-380
28 Giles TL, Lasserson TJ, Smith BH et al. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006; CD001106
29 Verse T, Bodlaj R, de la Chaux R et al. Leitlinie: Therapie der obstruktiven Schlafapnoe des Erwachsenen. HNO 2009; 57: 1136-1156
30 Randerath WJ, Verbraecken J, Andreas S et al. Non-CPAP-Therapies in obstructive sleep apnoea. Eur Respir J 2011; 37: 1000-1028
31 Peppard PE, Young T, Palta M et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000; 284: 3015-3021
32 Newman AB, Foster G, Givelber R et al. Progression and regression of sleep-disordered breathing with changes in weight: the Sleep Heart Health Study. Arch Intern Med 2005; 165: 2408-2413
33 Isono S. Obesity and obstructive sleep apnoea: mechanisms for increased collapsibility of the passive pharyngeal airway. Respirology 2012; 17: 32-42
34 Morgenthaler TI, Kapen S, Lee-Chiong T et al. Practice parameters for the medical therapy of obstructive sleep apnea. Sleep 2006; 29: 1031-1035
35 Foster GD, Borradaile KE, Sanders MH et al. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study. Arch Intern Med 2009; 169: 1619-1626
36 Tuomilehto HP, Seppa JM, Partinen MM et al. Lifestyle intervention with weight reduction: first-line treatment in mild obstructive sleep apnea. Am J Respir Crit Care Med 2009; 179: 320-327
37 Lam B, Sam K, Mok WY et al. Randomised study of three non-surgical treatments in mild to moderate obstructive sleep apnoea. Thorax 2007; 62: 354-359
38 Cartwright RD. Effect of sleep position on sleep apnea severity. Sleep 1984; 7: 110-114
39 Oksenberg A, Silverberg DS, Arons E et al. Positional vs nonpositional obstructive sleep apnea patients: anthropomorphic, nocturnal polysomnographic, and multiple sleep latency test data. Chest 1997; 112: 629-639
40 Oksenberg A, Silverberg D, Offenbach D et al. Positional therapy for obstructive sleep apnea patients: A 6-month follow-up study. Laryngoscope 2006; 116: 1995-2000
41 Wenzel S, Smith E, Leiacker R et al. [Efficacy and longterm compliance of the vest preventing the supine position in patients with obstructive sleep apnea]. Laryngorhinootologie 2007; 86: 579-583
42 Maurer JT, Stuck BA, Hein G et al. [Treatment of obstructive sleep apnea with a new vest preventing the supine position]. Dtsch Med Wochenschr 2003; 128: 71-75
43 Randerath WJ, Heise M, Hinz R et al. An individually adjustable oral appliance vs continuous positive airway pressure in mild-to-moderate obstructive sleep apnea syndrome. Chest 2002; 122: 569-575
44 Marklund M, Verbraecken J, Randerath W. Non-CPAP-Therapies in obstructive sleep apnoea mandibular advancement device therapy. Eur Respir J 2011; 37: 1000-1028
45 Chan AS, Sutherland K, Schwab RJ et al. The effect of mandibular advancement on upper airway structure in obstructive sleep apnoea. Thorax 2010; 65: 726-732
46 Kyung SH, Park YC, Pae EK. Obstructive sleep apnea patients with the oral appliance experience pharyngeal size and shape changes in three dimensions. Angle Orthod 2005; 75: 15-22
47 Ng AT, Gotsopoulos H, Qian J et al. Effect of oral appliance therapy on upper airway collapsibility in obstructive sleep apnea. Am J Respir Crit Care Med 2003; 168: 238-241
48 Vanderveken OM, Devolder A, Marklund M et al. Comparison of a custom-made and a thermoplastic oral appliance for the treatment of mild sleep apnea. Am J Respir Crit Care Med 2008; 178: 197-202
49 Dort LC, Hadjuk E, Remmers JE. Mandibular advancement and obstructive sleep apnoea: a method for determining effective mandibular protrusion. Eur Respir J 2006; 27: 1003-1009
50 Kato J, Isono S, Tanaka A et al. Dose-dependent effects of mandibular advancement on pharyngeal mechanics and nocturnal oxygenation in patients with sleep-disordered breathing. Chest 2000; 117: 1065-1072
51 Ferguson KA, Cartwright R, Rogers R et al. Oral appliances for snoring and obstructive sleep apnea: a review. Sleep 2006; 29: 244-262
52 Pitsis AJ, Darendeliler MA, Gotsopoulos H et al. Effect of vertical dimension on efficacy of oral appliance therapy in obstructive sleep apnea. Am J Respir Crit Care Med 2002; 166: 860-864
53 Gotsopoulos H, Chen C, Qian J et al. Oral appliance therapy improves symptoms in obstructive sleep apnea: a randomized, controlled trial. Am J Respir Crit Care Med 2002; 166: 743-748
54 Marklund M, Stenlund H, Franklin KA. Mandibular advancement devices in 630 men and women with obstructive sleep apnea and snoring: tolerability and predictors of treatment success. Chest 2004; 125: 1270-1278
55 Hoekema A, Stegenga B, Wijkstra PJ et al. Obstructive sleep apnea therapy. J Dent Res 2008; 87: 882-887
56 Liu Y, Lowe AA, Fleetham JA et al. Cephalometric and physiologic predictors of the efficacy of an adjustable oral appliance for treating obstructive sleep apnea. Am J Orthod Dentofacial Orthop 2001; 120: 639-647
57 Ferguson KA, Ono T, Lowe AA et al. A short-term controlled trial of an adjustable oral appliance for the treatment of mild to moderate obstructive sleep apnoea. Thorax 1997; 52: 362-368
58 Ferguson KA, Ono T, Lowe AA et al. A randomized crossover study of an oral appliance vs nasal-continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnea. Chest 1996; 109: 1269-1275
59 Engleman HM, McDonald JP, Graham D et al. Randomized crossover trial of two treatments for sleep apnea/hypopnea syndrome: continuous positive airway pressure and mandibular repositioning splint. Am J Respir Crit Care Med 2002; 166: 855-859
60 Barnes M, McEvoy RD, Banks S et al. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med 2004; 170: 656-664
61 Tan YK, L'Estrange PR, Luo YM et al. Mandibular advancement splints and continuous positive airway pressure in patients with obstructive sleep apnoea: a randomized cross-over trial. Eur J Orthod 2002; 24: 239-249
62 Walker-Engstrom ML, Ringqvist I, Vestling O et al. A prospective randomized study comparing two different degrees of mandibular advancement with a dental appliance in treatment of severe obstructive sleep apnea. Sleep Breath 2003; 7: 119-130
63 Kushida CA, Morgenthaler TI, Littner MR et al. Practice parameters for the treatment of snoring and Obstructive Sleep Apnea with oral appliances: an update for 2005. Sleep 2006; 29: 240-243
64 Villa MP, Malagola C, Pagani J et al. Rapid maxillary expansion in children with obstructive sleep apnea syndrome: 12-month follow-up. Sleep Med 2007; 8: 128-134
65 Pirelli P, Saponara M, Guilleminault C. Rapid maxillary expansion in children with obstructive sleep apnea syndrome. Sleep 2004; 27: 761-766
66 Villa MP, Rizzoli A, Miano S et al. Efficacy of rapid maxillary expansion in children with obstructive sleep apnea syndrome: 36 months of follow-up. Sleep Breath 2011; 15: 179-184
67 Guilleminault C, Li KK. Maxillomandibular expansion for the treatment of sleep-disordered breathing: preliminary result. Laryngoscope 2004; 114: 893-896
68 Guimaraes KC, Drager LF, Genta PR et al. Effects of oropharyngeal exercises on patients with moderate obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2009; 179: 962-966
69 Puhan MA, Suarez A, Lo CC et al. Didgeridoo playing as alternative treatment for obstructive sleep apnoea syndrome: randomised controlled trial. BMJ 2006; 332: 266-270
70 Randerath WJ, Galetke W, Domanski U et al. Tongue-muscle training by intraoral electrical neurostimulation in patients with obstructive sleep apnea. Sleep 2004; 27: 254-259
71 Schwartz AR, Eisele DW, Hari A et al. Electrical stimulation of the lingual musculature in obstructive sleep apnea. J Appl Physiol 1996; 81: 643-652
72 Miki H, Hida W, Chonan T et al. Effects of submental electrical stimulation during sleep on upper airway patency in patients with obstructive sleep apnea. Am Rev Respir Dis 1989; 140: 1285-1289
73 Van de Heyning PH, Badr MS, Baskin JZ et al. Implanted upper airway stimulation device for obstructive sleep apnea. Laryngoscope 2012; 122: 1626-1633
74 Friedman M, Tanyeri H, La RM et al. Clinical predictors of obstructive sleep apnea. Laryngoscope 1999; 109: 1901-1907
75 Nakata S, Miyazaki S, Ohki M et al. Reduced nasal resistance after simple tonsillectomy in patients with obstructive sleep apnea. Am J Rhinol 2007; 21: 192-195
76 Nakata S, Noda A, Yanagi E et al. Tonsil size and body mass index are important factors for efficacy of simple tonsillectomy in obstructive sleep apnoea syndrome. Clin Otolaryngol 2006; 31: 41-45
77 Won CH, Li KK, Guilleminault C. Surgical treatment of obstructive sleep apnea: upper airway and maxillomandibular surgery. Proc Am Thorac Soc 2008; 5: 193-199
78 Pirsig W, Schafer J, Yildiz F et al. [Uvulopalatopharyngoplasty without complications: a Fujita complication]. Laryngorhinootologie 1989; 68: 585-590
79 Sher AE. Upper airway surgery for obstructive sleep apnea. Sleep Med Rev 2002; 6: 195-212
80 Elshaug AG, Moss JR, Southcott AM et al. Redefining success in airway surgery for obstructive sleep apnea: a meta analysis and synthesis of the evidence. Sleep 2007; 30: 461-467
81 Walker-Engstrom ML, Tegelberg A, Wilhelmsson B et al. 4-year follow-up of treatment with dental appliance or uvulopalatopharyngoplasty in patients with obstructive sleep apnea: a randomized study. Chest 2002; 121: 739-746
82 Kezirian EJ, Weaver EM, Yueh B et al. Incidence of serious complications after uvulopalatopharyngoplasty. Laryngoscope 2004; 114: 450-453
83 Friedman M, Schalch P, Lin HC et al. Palatal implants for the treatment of snoring and obstructive sleep apnea/hypopnea syndrome. Otolaryngol Head Neck Surg 2008; 138: 209-216
84 Woodson BT, Steward DL, Weaver EM et al. A randomized trial of temperature-controlled radiofrequency, continuous positive airway pressure, and placebo for obstructive sleep apnea syndrome. Otolaryngol Head Neck Surg 2003; 128: 848-861
85 Lin HC, Friedman M, Chang HW et al. The efficacy of multilevel surgery of the upper airway in adults with obstructive sleep apnea/hypopnea syndrome. Laryngoscope 2008; 118: 902-908
86 Hochban W, Brandenburg U, Peter JH. Surgical treatment of obstructive sleep apnea by maxillomandibular advancement. Sleep 1994; 17: 624-629
87 Prinsell JR. Maxillomandibular advancement surgery in a site-specific treatment approach for obstructive sleep apnea in 50 consecutive patients. Chest 1999; 116: 1519-1529
88 Conradt R, Hochban W, Heitmann J et al. Sleep fragmentation and daytime vigilance in patients with OSA treated by surgical maxillomandibular advancement compared to CPAP therapy. J Sleep Res 1998; 7: 217-223
89 Li KK, Powell NB, Riley RW et al. Long-Term Results of Maxillomandibular Advancement Surgery. Sleep Breath 2000; 4: 137-140
90 Genecov DG, Barcelo CR, Steinberg D et al. Clinical experience with the application of distraction osteogenesis for airway obstruction. J Craniofac Surg 2009; 20: 1817-1821
91 Flores RL, Shetye PR, Zeitler D et al. Airway changes following Le Fort III distraction osteogenesis for syndromic craniosynostosis: a clinical and cephalometric study. Plast Reconstr Surg 2009; 124: 590-601
92 Wang X, Wang XX, Liang C et al. Distraction osteogenesis in correction of micrognathia accompanying obstructive sleep apnea syndrome. Plast Reconstr Surg 2003; 112: 1549-1557
93 Li KK, Powell NB, Riley RW et al. Distraction osteogenesis in adult obstructive sleep apnea surgery: a preliminary report. J Oral Maxillofac Surg 2002; 60: 6-10
94 Fujita S. UPPP for sleep apnea and snoring. Ear Nose Throat J 1984; 63: 227-235
95 Riley RW, Powell NB, Guilleminault C. Obstructive sleep apnea syndrome: a review of 306 consecutively treated surgical patients. Otolaryngol Head Neck Surg 1993; 108: 117-125